LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 106 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -50.0% | 17,521 | -60.6% | 0.00% | -57.1% |
| Q4 2022 | $52 | -99.5% | 44,442 | +343.2% | 0.01% | +600.0% |
| Q3 2022 | $11,000 | -47.6% | 10,028 | -25.1% | 0.00% | -50.0% |
| Q2 2022 | $21,000 | -86.4% | 13,380 | -75.3% | 0.00% | -86.7% |
| Q2 2021 | $154,000 | +305.3% | 54,131 | +34.3% | 0.02% | +114.3% |
| Q3 2020 | $38,000 | -44.1% | 40,318 | -48.3% | 0.01% | -12.5% |
| Q2 2020 | $68,000 | – | 78,042 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $55,198,000 | 4.16% |
| Raffles Associates | 1,930,536 | $3,050,000 | 3.32% |
| Defender Capital, LLC. | 5,131,935 | $8,108,000 | 3.18% |
| Prescott General Partners LLC | 1,851,851 | $2,926,000 | 0.20% |
| DAFNA Capital Management LLC | 140,000 | $221,000 | 0.06% |
| Laurion Capital Management LP | 2,422,367 | $3,827,000 | 0.06% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $71,000 | 0.05% |
| Fort Sheridan Advisors LLC | 78,931 | $125,000 | 0.04% |
| Long Focus Capital Management, LLC | 215,000 | $340,000 | 0.04% |
| MORGAN JESS S & CO INC | 20,000 | $32,000 | 0.03% |